This document is a stock and sales report from M/S.SUPRABHAT PHARMACEUTICALS for the period of April 1st to April 10th. It provides information on inventory levels, purchases, sales, credits, and adjustments for various medication items manufactured by Cadila Pharma. Key details include an opening inventory value of Rs. 93887.87, total sales of Rs. 7736.05, and a closing inventory value of Rs. 84303.41.
This document is a stock and sales report from M/S.SUPRABHAT PHARMACEUTICALS for the period of April 1st to April 10th. It provides information on inventory levels, purchases, sales, credits, and adjustments for various medication items manufactured by Cadila Pharma. Key details include an opening inventory value of Rs. 93887.87, total sales of Rs. 7736.05, and a closing inventory value of Rs. 84303.41.
This document is a stock and sales report from M/S.SUPRABHAT PHARMACEUTICALS for the period of April 1st to April 10th. It provides information on inventory levels, purchases, sales, credits, and adjustments for various medication items manufactured by Cadila Pharma. Key details include an opening inventory value of Rs. 93887.87, total sales of Rs. 7736.05, and a closing inventory value of Rs. 84303.41.